Pharmacological options for those who experience migraines come in the form of abortive or preventative therapies.
Laura Momoko Asakura, PharmD, BCOP, BCSPS, discusses the equitable use of oncology treatment pathway tools, highlighting that their utilization remains consistent across patient groups regardless of race, ethnicity, or insurance status.
Myths, fears, distrust, and misinformation on immunizations can keep patients from benefiting from their protective effects.
Novel drug development has been focused on the augmentation of the T-lymphocyte response.
Elizabeth Spurlock, MA, PHR, director of HR Business Partner at Texas Oncology, discusses how burnout among physicians, nurses, and hospital administrators has impacted the role of the pharmacist in patient care.
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Because pharmacists are one of the most accessible health care providers, we are trained in medication selection and in how to counsel patients who wish to stop smoking.
The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.
The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.
Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Understanding the categories is key to evaluating and making decisions about outsourcing products or improving internal production standards.
Coloring can be a form of mindfulness and promotes relaxation and reduces stress, which is particularly valuable in the fast-paced world of health care.
Developing an antimicrobial stewardship program is arduous but valuable; commitment from leadership is the first step.
Empiric anti-MRSA therapy is an area of opportunity for antimicrobial stewardship in the treatment of CAP.
Case management programs or pharmacist-delivered high-touch care are critical components in medical specialty drug management.
Pharmacists play a key role in migraine management, therefore, awareness of menstrual migraine-specific prophylaxis is important.
Best practices to train staff and team members to engage patients and to ease the new vaccine offerings into the workflow are also discussed.
Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Ready-to-use glucagon simplifies hypoglycemia rescue by providing easy-to-use options for patients and caregivers.
From certified medical assistants to phlebotomy technicians, the need for positive patient-provider interactions has proven critical both in achieving high patient satisfaction rates and improving patient experience.
Pharmacists in community-based settings are now capable of developing innovative pharmacy practices and offering patient care services.
Community pharmacists’ influence increases the likelihood of patients safely disposing unused medications and keeping them out of harm’s reach.
Data have shown the potential for the therapy to treat several new conditions.
Modern society has put individuals at an increased risk of dopamine overload, causing an increase in mental health disorders.
Pharmacists have an evolving role in biotechnology.
In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.